Kim Pyung-Wha, Choe Seon, Han Kyungsun, Yang Changsop, Lee Jinbok, Kim Sungha, Shin Minseop
Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Republic of Korea.
J Pharmacopuncture. 2021 Jun 30;24(2):76-83. doi: 10.3831/KPI.2021.24.2.76.
While carpal tunnel syndrome (CTS) is the most common entrapment neuropathy affecting the wrist, resulting in substantial physical, psychological, and economic effects, there is no gold standard therapy for CTS. In this case series study, we aimed to report CTS patients treated with Pharmacopuncture (CSP) and electroacupuncture (EA) showing improvements in their symptoms, and the combinatorial effects of CSP and EA. We collected medical records of CTS outpatients who received CSP and EA at Chuk-u Acupuncture & Moxibustion Korean Medicine Clinic from August 2017 to September 2018. The outcome measures were the visual analog scale (VAS) for pain, paresthesia, the Korean version of the Boston carpal tunnel questionnaire (K-BCTQ) score, and changes in nocturnal pain, Tinel sign, and Phalen's test. We included patient satisfaction at the completion of all treatments. 17 patients were included for this case series study. After treatment, VAS for pain decreased significantly from 50.41 ± 16.19 to 9.59 ± 9.46, VAS for paresthesia also decreased significantly from 63.50 ± 11.49 to 14.75 ± 12.97, and K-BCTQ symptom severity scale decreased from 2.48 ± 0.68 to 1.89 ± 0.70 (all p < 0.001). Nocturnal pain, Tinel signs, and Phalen's test showed improvements after all the treatments. All the patients reported favorable overall satisfaction with the treatments, and 69.23% wanted future pharmacopuncture treatments if CTS recurred. No complications were detected. The combination of CSP and EA could be an effective and safe option in treating CTS.
虽然腕管综合征(CTS)是影响手腕的最常见的卡压性神经病,会对身体、心理和经济造成重大影响,但目前尚无治疗CTS的金标准疗法。在本病例系列研究中,我们旨在报告接受药针疗法(CSP)和电针疗法(EA)治疗后症状有所改善的CTS患者,以及CSP和EA的联合效果。我们收集了2017年8月至2018年9月在忠武针灸韩医诊所接受CSP和EA治疗的CTS门诊患者的病历。观察指标包括疼痛、感觉异常的视觉模拟量表(VAS)、波士顿腕管问卷韩文版(K-BCTQ)评分,以及夜间疼痛、Tinel征和Phalen试验的变化。我们纳入了所有治疗结束时的患者满意度。本病例系列研究共纳入17例患者。治疗后,疼痛VAS评分从50.41±16.19显著降至9.59±9.46,感觉异常VAS评分也从63.50±11.49显著降至14.75±12.97,K-BCTQ症状严重程度量表从2.48±0.68降至1.89±0.70(所有p<0.001)。所有治疗后夜间疼痛、Tinel征和Phalen试验均有改善。所有患者对治疗的总体满意度良好,69.23%的患者表示如果CTS复发,希望未来接受药针治疗。未发现并发症。CSP和EA联合使用可能是治疗CTS的一种有效且安全的选择。